Please login to the form below

Not currently logged in
Email:
Password:

Sarah Verhoeff joins the board at Pan

UK advertising agency promotes its associate director

Pan Sarah VerhoeffSarah Verhoeff has been appointed to the board of UK-based creative agency Pan.

Verhoeff is a relative newcomer to Pan, having joined as associate director in January from Havas Life (then known as Euro RSCG Life), where she was business director at the UK office.

Pan managing director Jon Linscott said that the agency was delighted to promote Verhoeff, who has become 'an integral member of the team' and will be working on the development of HTML5 iPad detail aid builds under Pan's recently launched in-house capability.

“Since joining Pan she has clearly demonstrated her incredible expertise, deep thinking and skilful execution of client business as well as a very strong role in the development of the company and its people,” he said.

Verhoeff joins Emily Wigginton, director; Julia Straker, director of strategic brand planning; and Arron O'Hare, creative director, on the Pan board. Among her responsibilities will be leading key clients such as Otsuka/Lundbeck, Takeda, Astellas, UCB, GSK, Linscott told PMLiVE.

“This  appointment means that Pan now has a senior team with the right balance of skills and experience to ensure that we're exceeding client expectations when it comes to creating influential creativity for the brands for which we are responsible,” Linscott added.

26th September 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics